Articles
by M.Espi, X.Charmetant (...) and O.Thaunat, Kidney International 2021, DOI : 10.1016/j.kint.2021.10.040
Travel Med Infect Dis.
Espi M, Charmetant X, et al, Kid Int 2021
C. Allam et al. Emerging Infectious Diseases Volume 27, Number 11—November 2021
Lucifora, Pastor et al., JHep Reports, 2021 / Team HepVir
ALPK1 is a kinase sensing a bacterial metabolite from the LPS biosynthesis pathway. Our favorite clinician describes a new family of patients. This rare monogenic disease associated with vision loss is still poorly known in the field of autoinflammation and this description of a new family of patients should raise awareness on the inflammatory symptoms associated with this disease.
Unreported control of Type 4 secretion by the second messenger c-di-GMP signaling is revealed
Prognostic factors of severe community-acquired staphylococcal pneumonia in France